ZA928297B - Quinoline derivatives, process for their preparation, and their therapeutic applications. - Google Patents
Quinoline derivatives, process for their preparation, and their therapeutic applications.Info
- Publication number
- ZA928297B ZA928297B ZA928297A ZA928297A ZA928297B ZA 928297 B ZA928297 B ZA 928297B ZA 928297 A ZA928297 A ZA 928297A ZA 928297 A ZA928297 A ZA 928297A ZA 928297 B ZA928297 B ZA 928297B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- alkoxy
- aryl
- independently
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
Abstract
Compounds corresponding to the formula (I) <IMAGE> in which, R1 represents either a 1H-tetrazol-5-yl group or a CO2H group, R2 represents either a (C1-7)alkyl group or a (C2-6)alkenyl group, R3 and R4 represent, each independently of the other, either a hydrogen atom, or a halogen atom, or a cyano group, or a (C1-7)alkyl group, or a (C3-7)cycloalkyl(C1-4)alkyl group, or an aryl group, or an aryl(C1-4)alkyl group, or an aryl(C2-4)alkenyl group, or a group -(CH2)mCOR5 in which m = 0 to 4 and R5 represents a hydrogen atom, an OH group, a (C1-6)alkoxy group or a group NR7R8, R7 and R8 representing, each independently of the other, a hydrogen atom or a (C1-4)alkyl group, or R3 and R4 represents, each independently of the other, a group -(CH2)n-R6 in which n = 1 to 4 and R6 represents an OH group, a (C1-6)alkoxy group, a (C1-4)alkoxy(C1-4)alkoxy group or a (C3-7)cycloalkyl(C1-4)alkoxy group, and their pharmaceutically acceptable organic or inorganic salts. Application in therapeutics.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9113240A FR2683819B1 (en) | 1991-10-28 | 1991-10-28 | QUINOLEIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA928297B true ZA928297B (en) | 1993-05-07 |
Family
ID=9418349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA928297A ZA928297B (en) | 1991-10-28 | 1992-10-27 | Quinoline derivatives, process for their preparation, and their therapeutic applications. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0540400B1 (en) |
JP (1) | JPH05239053A (en) |
KR (1) | KR930007935A (en) |
CN (1) | CN1073171A (en) |
AT (1) | ATE126798T1 (en) |
AU (1) | AU651740B2 (en) |
CA (1) | CA2081537A1 (en) |
CZ (1) | CZ324292A3 (en) |
DE (1) | DE69204252T2 (en) |
FI (1) | FI924869A (en) |
FR (1) | FR2683819B1 (en) |
HU (1) | HUT62883A (en) |
IL (1) | IL103568A0 (en) |
MX (1) | MX9206169A (en) |
NO (1) | NO924138L (en) |
NZ (1) | NZ244892A (en) |
PL (1) | PL296369A1 (en) |
ZA (1) | ZA928297B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5478832A (en) * | 1992-05-08 | 1995-12-26 | The Green Cross Corporation | Quinoline compounds |
IT1255461B (en) * | 1992-07-28 | 1995-11-02 | Luso Farmaco Inst | ETHERS OF IMIDAZOLI ACTIVATED IN II ANTAGONIST |
FR2699174B1 (en) * | 1992-12-14 | 1995-01-20 | Synthelabo | Derivatives of 3- (quinoline-6-yl-methyl) -4H-imidazol-4-one, their preparation and their therapeutic use. |
FR2710914B1 (en) * | 1993-10-04 | 1995-11-24 | Synthelabo | 2- [2- (tetrazol-5-yl) phenyl] -1,2-dihydroquinoline derivatives, their preparation and their use as synthesis intermediates. |
FR2716196B1 (en) * | 1994-02-16 | 1996-04-05 | Synthelabo | 8- [2- (1H-tetrazol-5-yl) phenyl] quinoline derivatives, their preparation and their therapeutic use. |
JPH09202774A (en) | 1996-01-25 | 1997-08-05 | Green Cross Corp:The | 2-arylquinoline and its production |
DE19706161A1 (en) * | 1997-02-17 | 1998-08-20 | Oswald Hartmut Prof Dr Med | Use of cyanines, isocyanines and pseudoisocyanines as diuretics |
KR100744826B1 (en) * | 2006-04-05 | 2007-08-01 | 한국화학연구원 | Quinolinone derivatives substituted with imidazole group |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CA2688161C (en) | 2007-06-04 | 2020-10-20 | Kunwar Shailubhai | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
ES2522968T3 (en) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
ES2624828T3 (en) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CN103804349A (en) * | 2012-11-01 | 2014-05-21 | 杨子娇 | Compounds for treatment of glaucoma and their use |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
JP6606491B2 (en) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | Ultra high purity agonist of guanylate cyclase C, method for producing and using the same |
CN108558750B (en) * | 2018-07-11 | 2021-01-05 | 武汉工程大学 | Process for synthesizing 3-nitroquinoline derivative by solvent-free method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94390A (en) * | 1989-05-30 | 1996-03-31 | Merck & Co Inc | Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them |
MX9200299A (en) * | 1991-02-07 | 1992-12-01 | Roussel Uclaf | NEW NITROGENATED BICYCLE DERIVATIVES, THEIR PROCEDURE FOR PREPARING THE NEW INTERMEDIATE COMPOUNDS OBTAINED THEIR APPLICATION AS MEDICINES AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
DE4117750A1 (en) * | 1991-05-30 | 1992-12-24 | Bayer Ag | NEW 2-AMINO-5-CYANO-1,4-DIHYDROPYRIDINE, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS |
ATE152718T1 (en) * | 1991-08-15 | 1997-05-15 | Ciba Geigy Ag | N-ACYL-N-HETEROCYCLYL OR NAPHTHYLALKYL AMINO ACIDS AS ANGIOTENSIN II ANTAGONISTS |
-
1991
- 1991-10-28 FR FR9113240A patent/FR2683819B1/en not_active Expired - Fee Related
-
1992
- 1992-10-22 AT AT92402879T patent/ATE126798T1/en active
- 1992-10-22 EP EP92402879A patent/EP0540400B1/en not_active Revoked
- 1992-10-22 DE DE69204252T patent/DE69204252T2/en not_active Revoked
- 1992-10-27 JP JP4288458A patent/JPH05239053A/en active Pending
- 1992-10-27 AU AU27348/92A patent/AU651740B2/en not_active Ceased
- 1992-10-27 NZ NZ244892A patent/NZ244892A/en unknown
- 1992-10-27 FI FI924869A patent/FI924869A/en not_active Application Discontinuation
- 1992-10-27 CZ CS923242A patent/CZ324292A3/en unknown
- 1992-10-27 KR KR1019920019802A patent/KR930007935A/en not_active Application Discontinuation
- 1992-10-27 MX MX9206169A patent/MX9206169A/en unknown
- 1992-10-27 NO NO92924138A patent/NO924138L/en unknown
- 1992-10-27 HU HU9203374A patent/HUT62883A/en unknown
- 1992-10-27 PL PL29636992A patent/PL296369A1/en unknown
- 1992-10-27 CN CN92113784A patent/CN1073171A/en active Pending
- 1992-10-27 CA CA002081537A patent/CA2081537A1/en not_active Abandoned
- 1992-10-27 ZA ZA928297A patent/ZA928297B/en unknown
- 1992-10-27 IL IL103568A patent/IL103568A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATE126798T1 (en) | 1995-09-15 |
CN1073171A (en) | 1993-06-16 |
JPH05239053A (en) | 1993-09-17 |
FI924869A0 (en) | 1992-10-27 |
MX9206169A (en) | 1993-07-01 |
HU9203374D0 (en) | 1993-01-28 |
IL103568A0 (en) | 1993-03-15 |
AU651740B2 (en) | 1994-07-28 |
CZ324292A3 (en) | 1993-09-15 |
NZ244892A (en) | 1994-06-27 |
CA2081537A1 (en) | 1993-04-29 |
KR930007935A (en) | 1993-05-20 |
DE69204252T2 (en) | 1996-04-18 |
AU2734892A (en) | 1993-04-29 |
FR2683819A1 (en) | 1993-05-21 |
EP0540400A1 (en) | 1993-05-05 |
FR2683819B1 (en) | 1994-02-11 |
HUT62883A (en) | 1993-06-28 |
EP0540400B1 (en) | 1995-08-23 |
DE69204252D1 (en) | 1995-09-28 |
NO924138D0 (en) | 1992-10-27 |
PL296369A1 (en) | 1993-05-31 |
NO924138L (en) | 1993-04-29 |
FI924869A (en) | 1993-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL103568A0 (en) | Quinoline derivatives,process for their preparation and their therapeutic applications | |
ES2076827T3 (en) | AZAINDOLS, PREPARATION PROCEDURES AND CONTAINING MEDICINES. | |
DE69103206D1 (en) | New derivatives of aminopiperidine, aminopyrrolidine and aminoperhydroazepine, process for their preparation and medicaments containing them. | |
DE69210875T2 (en) | Piperidine derivatives, processes for their preparation and their therapeutic use | |
MX9202803A (en) | NEW BENZOPYRAN COMPOUNDS AND PROCEDURE FOR THE PREPARATION. | |
IL103601A0 (en) | Phthalazines containing an ether or thioether group in the 1-position,their preparation and pharmaceutical compositions containing them | |
ZA921203B (en) | 4-pyrimidinone derivatives,their preparation and their application in therapy | |
GB2110669B (en) | Imidazolidinones | |
GR3020292T3 (en) | Use of 2-iminothiazolidin-4-one derivatives as new medicaments | |
GR3000488T3 (en) | Novel 1,4-dihydropyridines containing fluorine, process for their preparation and their use as medicaments | |
GR3019362T3 (en) | Tetrahydronaphtalene derivatives, their preparation and their application in therapy | |
GR3015212T3 (en) | Ethanolaminebenzoate derivative, process for their preparation and pharmaceutical compositions containing them. | |
JO1825B1 (en) | Therapeutic agents |